Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants

Bibliography

• Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2009;24:117-25
   PubMed Web of Science ®Google Scholar
• Rappaport SM. Discovering environmental causes of disease. J Epidemiol Community Health 2010;66:99-102
   Web of Science ®Google Scholar
• Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005;28:249-68
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Genetic basis of toxic reactions to drugs and chemicals. Toxicol Lett 2006;162:16-28
   PubMed Web of Science ®Google Scholar
• Pinto N, Dolan ME. Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab 2011;12:487-97
   PubMed Web of Science ®Google Scholar
• Hirota T, Takane H, Higuchi S, Ieiri I. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms. Curr Drug Metab 2008;9:34-8
   PubMed Web of Science ®Google Scholar
• Ma Q. Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem Res Toxicol 2008;21:1651-71
   PubMed Web of Science ®Google Scholar
• Yu AM. Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 2009;5:1513-28
   PubMed Web of Science ®Google Scholar
• Yokoi T, Nakajima M. Toxicological implications of modulation of gene expression by microRNAs. Toxicol Sci 2011;123:1-14
   PubMed Web of Science ®Google Scholar
• Rukov JL, Shomron N. MicroRNA pharmacogenomics: post-translational regulation of drug response. Trends Mol Med 2011;17:412-23
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
   PubMed Web of Science ®Google Scholar
• Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-40
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010;79:351-79
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60
   PubMed Web of Science ®Google Scholar
• Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006;13:1097-101
   PubMed Web of Science ®Google Scholar
• Schnall-Levin M, Rissland OS, Johnston WK, Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. Genome Res 2011;21:1395-403
   Google Scholar
• Bhayani MK, Calin GA, Lai SY. Functional relevance of miRNA* sequences in human disease. Mutat Res 2012;731:14-19
   PubMed Web of Science ®Google Scholar
• Kim VN, Nam JW. Genomics of microRNA. Trends Genet 2006;22:165-73
   PubMed Web of Science ®Google Scholar
• Breving K, Esquela-Kerscher A. The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 2010;42:1316-29
   PubMed Web of Science ®Google Scholar
• O'Donnell KA, Wentzel EA, Zeller KI, c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, A microRNA component of the p53 tumor suppressor network. Nature 2007;447:1130-4
   PubMed Web of Science ®Google Scholar
• Chang TC, Yu D, Lee YS, Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010;9:775-89
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002;99:15524-9
   PubMed Web of Science ®Google Scholar
• Mishra PJ, Bertino JR. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009;10:399-416
   PubMed Web of Science ®Google Scholar
• Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R. Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 2012;16:8-21
   PubMed Web of Science ®Google Scholar
• Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010;10:389-402
   PubMed Web of Science ®Google Scholar
• Mishra PJ, Humeniuk R, Mishra PJ, A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 2007;104:13513-18
   PubMed Web of Science ®Google Scholar
• Xiong F, Wu C, Chang J, Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res 2011;71:5175-81
   Google Scholar
• Saito Y, Liang G, Egger G, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9:435-43
   PubMed Web of Science ®Google Scholar
• Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007;6:1001-5
   PubMed Web of Science ®Google Scholar
• Kunej T, Godnic I, Ferdin J, Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 2011;717:77-84
   PubMed Web of Science ®Google Scholar
• Han L, Witmer PD, Casey E, DNA methylation regulates microRNA expression. Cancer Biol Ther 2007;6:1284-8
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KKH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92-105
   PubMed Web of Science ®Google Scholar
• Lal A, Kim HH, Abdelmohsen K, p16(INK4a) translation suppressed by miR-24. PLoS ONE 2008;3:e1864
   PubMed Web of Science ®Google Scholar
• Duursma AM, Kedde M, Schrier M, miR-148 targets human DNMT3b protein coding region. RNA 2008;14:872-7
   PubMed Web of Science ®Google Scholar
• Tay Y, Zhang J, Thomson AM, MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008;455:1124-8
   PubMed Web of Science ®Google Scholar
• Place RF, Li LC, Pookot D, MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 2008;105:1608-13
   PubMed Web of Science ®Google Scholar
• Turesky RJ, Le Marchand L. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol 2011;24:1169-214
   PubMed Web of Science ®Google Scholar
• Shimada T, Hayes CL, Yamazaki H, Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 1996;56:2979-84
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Takagi S, MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 2006;66:9090-8
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Filkowski J, Meservy J, Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008;7:2152-9
   PubMed Web of Science ®Google Scholar
• Pandey DP, Picard D. MiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009;29:3783-90
   PubMed Web of Science ®Google Scholar
• Adams BD, Cowee DM, White BA. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and luminal phenotype in MCF-7 breast cancer cells. Mol Endocrinol 2009;23:1215-30
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Lin J, Yang H, MicroRNA-221/222 negatively regulates estrogen receptor alpha and associated with tamoxifen resistance in breast cancer. J Biol Chem 2008;283:31079-86
   PubMed Web of Science ®Google Scholar
• Angus WG, Larsen MC, Jefcoate CR. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 1999;20:947-55
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Kyo S, Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004;64:3119-25
   PubMed Web of Science ®Google Scholar
• Song BJ, Gelboin HV, Park SS, Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem 1986;261:16689-97
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005;569:101-10
   PubMed Web of Science ®Google Scholar
• Trafalis DT, Panteli ES, Grivas A, CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol 2010;6:307-19
   PubMed Web of Science ®Google Scholar
• Mohri T, Nakajima M, Fukami T, Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 2010;79:1045-52
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Downes M, Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 2000;406:435-9
   PubMed Web of Science ®Google Scholar
• Thummel KE, Brimer C, Yasuda K, Transcriptional control of intestinal cytochrome P4503A by 1alpha,25-dihydroxy vitamin D3. Mol Pharmacol 2001;60:1399-406
   PubMed Web of Science ®Google Scholar
• Wang K, Mendy AJ, Dai G, Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci 2006;92:51-60
   PubMed Web of Science ®Google Scholar
• Pan YZ, Gao W, Yu AM. MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 2009;37:2112-17
   PubMed Web of Science ®Google Scholar
• Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154:103-16
   PubMed Web of Science ®Google Scholar
• Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev 2011;43:138-51
   PubMed Web of Science ®Google Scholar
• Uchida Y, Chiyomaru T, Enokida H, MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell. lines. Urol Oncol 2012; published online 9 March 2011
   PubMed Web of Science ®Google Scholar
• Mutallip M, Nohata N, Hanazawa T, Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133a in head and neck squampus cell carcinoma (HNSCC). Int J Mol Med 2011;27:345-52
   PubMed Web of Science ®Google Scholar
• Yu X, Dhakal IB, Beggs M, Functional genetic variants in the3'-untranslated region of the sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol Sci 2010;118:391-403
   PubMed Web of Science ®Google Scholar
• Huang TC, Chang HY, Chen CY, Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Lett 2011;585:3582-6
   PubMed Web of Science ®Google Scholar
• Ma Q. Xenobiotic-activated receptors: from transcription to drug metabolism to disease. Chem Res Toxicol 2008;21:1651-71
   PubMed Web of Science ®Google Scholar
• Slocum SL, Kensler TW. Nrf2: control of sensitivity to carcinogens. Arch Toxicol 2011;85:273-84
   PubMed Web of Science ®Google Scholar
• Yang M, Yao Y, Eades G, MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res Treat 2011;129:983-91
   PubMed Web of Science ®Google Scholar
• Li N, Muthusamy S, Liang R, Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech Ageing Dev 2011;132:75-85
   PubMed Web of Science ®Google Scholar
• Sangokoya C, Telen MJ, Chi JT. MicroRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 2010;116:4338-48
   PubMed Web of Science ®Google Scholar
• Eades G, Yang M, Yao Y, MiR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011;286:40725-33
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li F, Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res 2011;63:259-65
   PubMed Web of Science ®Google Scholar
• Takagi S, Nakajima M, Mohri T, Yokoi T. Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 2008;283:9674-80
   PubMed Web of Science ®Google Scholar
• Zhong XY, Yu JH, Zhang WG, MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene 2012;493:44-51
   PubMed Web of Science ®Google Scholar
• Ou Z, Wada T, Gramignoli R, MicroRNA has-miR-613 targets the human LXRalpha gene and mediates a feedback loop of LXRalpha autoregulation. Mol Endocrinol 2011;25:584-96
   PubMed Web of Science ®Google Scholar
• Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 2011;1812:1007-22
   PubMed Web of Science ®Google Scholar
• Zheng L, Lv GC, Sheng J, Yang YD. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 2010;25:156-63
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang KC, Wu W, MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 2011;108:10355-60
   PubMed Web of Science ®Google Scholar
• Tong JL, Zhang CP, Nie F, MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 2011;585:3560-8
   PubMed Web of Science ®Google Scholar
• Kida K, Nakajima M, Mohri T, PPARa is regulated by miR-21 and miR-27b in human liver. Pharm Res 2011;28:2467-76
   PubMed Web of Science ®Google Scholar
• Shah YM, Morimura K, Yang Q, Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol Cell Biol 2007;27:4238-47
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim AY, Lee HW, MiR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 2010;392:323-8
   PubMed Web of Science ®Google Scholar
• Jennewein C, von Knethen A, Schmid T, Brune B. MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 2010;285:11846-53
   PubMed Web of Science ®Google Scholar
• Lee EK, Lee MJ, Abdelmohsen K, MiR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol 2011;31:626-38
   PubMed Web of Science ®Google Scholar
• Szakacs G, Paterson JK, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006;5:219-34
   PubMed Web of Science ®Google Scholar
• Kioka N, Tsubota J, Kakehi Y, P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 1989;162:224-31
   PubMed Web of Science ®Google Scholar
• David GL, Yegnasubramanian S, Kumar A, MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. Cancer Biol Ther 2004;3:540-8
   PubMed Web of Science ®Google Scholar
• Chekhun VF, Lukyanova NY, Kovalchuk O, Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther 2007;6:1089-98
   PubMed Web of Science ®Google Scholar
• Zhu H, Wu H, Liu X, Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008;76:582-8
   PubMed Web of Science ®Google Scholar
• Li Z, Hu S, Wang J, MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol 2010;119:125-30
   PubMed Web of Science ®Google Scholar
• Mao Q, Unadkat JD. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J 2005;7:E118-33
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Schinkel AH. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins. Trends Pharmacol Sci 2006;27:10-16
   PubMed Web of Science ®Google Scholar
• Pan YZ, Moris ME, Yu AM. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009;75:1374-9
   PubMed Web of Science ®Google Scholar
• To KKW, Zhan Z, Litman T, Bates SE. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 2008;28:5147-61
   PubMed Web of Science ®Google Scholar
• Jedlitschky G, Leier I, Buchholz U, Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56:988-94
   PubMed Web of Science ®Google Scholar
• Konig J, Nies AT, Cui Y, Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochem Biophys Acta 1999;1461:377-94
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu H, Xia J, Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 2010;79:817-24
   PubMed Web of Science ®Google Scholar
• Pogribny IP, Filkowski JN, Tryndyak VP, Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cysplatin. Int J Cancer 2010;127:1785-94
   PubMed Web of Science ®Google Scholar
• Kutay H, Bai S, Datta J, Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006;99:671-8
   PubMed Web of Science ®Google Scholar
• Coulouarn C, Factor VM, Andersen JB, Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009;28:3526-36
   PubMed Web of Science ®Google Scholar
• Xu Y, Xia F, Ma L, MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Cancer Lett 2011;310:160-9
   PubMed Web of Science ®Google Scholar
• Haenisch S, Laechelt S, Bruckmueller H, Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after Rifampicin treatment is mediated by microRNA-379. Mol Pharmacol 2011;80:314-20
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yu F, Jiao Y, Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res 2011;15:7105-15.
   Google Scholar
• Borel F, Han R, Visser A, ATP-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 2012;55:821-32
   PubMed Web of Science ®Google Scholar
• Hou L, Wang D, Baccarelli A. Environmental chemicals and microRNAs. Mutat Res 2011;714:105-12
   PubMed Web of Science ®Google Scholar
• Zhang B, Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect 2009;117:231-40
   PubMed Web of Science ®Google Scholar
• Liu L, Jiang Y, Zhang H, MiR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicol In Vitro 2010;24:1168-75
   PubMed Web of Science ®Google Scholar
• Rager JE, Smeester L, Jaspers I, Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells. Environ Health Perspect 2011;119:494-500
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Marzolf B, Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106:4402-7
   PubMed Web of Science ®Google Scholar
• Laterza OF, Lim L, Garrett-Engele PW, Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009;55:1977-83
   PubMed Web of Science ®Google Scholar
• Yoshioka W, Higashiyama W, Tohyama C. Involvement of microRNAs in dioxin-induced liver damage in the mouse. Toxicol Sci 2011;122:457-65
   PubMed Web of Science ®Google Scholar
• Starkey Lewis PJ, Dear J, Platt V, Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011;54:1767-76
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, Plasma miR-208 as biomarker of myocardial injury. Clin Chem 2009;55:1944-9
   PubMed Web of Science ®Google Scholar
• Selbach M, Schwanhausser B, Thierfelder N, Widespread changes in protein synthesis induced by microRNAs. Nature 2008;455:58-63
   PubMed Web of Science ®Google Scholar
• Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 2006;21:257-76
   PubMed Web of Science ®Google Scholar